Modeling Alzheimer's Disease Related Dementias in the Marmoset

模拟狨猴中与阿尔茨海默病相关的痴呆症

• 批准号: 10618761
• 负责人: KUO-FEN LEE
• 金额: $ 93.72万
• 依托单位: SALK INSTITUTE FOR BIOLOGICAL STUDIES
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-16 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10618761
• 关键词: Aging; Alzheimer' s disease model; Alzheimer' s disease related dementia; Alzheimer' s disease risk; Amyloid beta-Protein; Amyotrophic Lateral Sclerosis; Apolipoprotein E; Apolipoproteins; Behavioral; Biochemical; Blood - brain barrier anatomy; Blood Vessels; Body Size; Brain; C9ORF72; CRISPR/Cas technology; Callithrix; Cognitive; Complex; Craniocerebral Trauma; Dementia; Development; Disease; Disease Progression; Doxycycline; Environment; Etiology; Event; Functional Magnetic Resonance Imaging; Genes; Genetic; Goals; Homeostasis; Housekeeping; Human; Immunologic Receptors; Impaired cognition; Infection; Inflammatory Response; Lewy Body Dementia; Ligands; Link; Longevity; Magnetic Resonance Imaging; Maintenance; Mammals; Mediating; Metabolism; Microglia; Modeling; Molecular; Molecular Disease; Mus; Mutation; Neuraxis; Neurons; Parkinson Disease; Pathologic; Pathology; Pathway interactions; Peptides; Personal Satisfaction; Phase; Phenotype; Play; Positron-Emission Tomography; Preclinical Testing; Primates; Process; Research; Risk Factors; Role; Series; Signal Pathway; Signal Transduction; Structure; Syndrome; TREM2 gene; Testing; Time; Transgenes; Transgenic Organisms; Variant; Vascular System; cell type; clinical diagnosis; cognitive testing; diagnostic tool; early onset; fluorodeoxyglucose positron emission tomography; frontotemporal degeneration; human disease; immune function; inducible gene expression; macrophage; metabolic fitness; mixed dementia; mouse model; mutant; neuroimaging; neuroinflammation; neuron loss; neuroprotection; non-genetic; nonhuman primate; null mutation; operation; prevent; promoter; protein TDP-43; reproductive; response; screening; social; success; therapeutic candidate; therapeutic evaluation; therapeutic target; tool; transgene expression; translational neuroscience; vascular cognitive impairment and dementia

Abstract The long-term goal of this project is to model Alzheimer's Disease related dementias (ADRD) in longer-living mammals. These multi-dimensional mammalian ADRD models, including frontotemporal degeneration (FTD), Lewy body dementia (LBD), vascular contributions to cognitive impairment and dementia (VCID), and mixed etiology dementias, are aimed at informing human ADRD across the disease-relevant stages and serve as tools to interrogate disease mechanisms and identify therapeutic targets. ADRD develops as a result of a complex series of events that take place in the brain over a long period of time—the prodromal phase can last 10-20 years in humans—before dementia is clinically diagnosed. Understanding this EARLY stage will be critically important for developing diagnostic tools (e.g., neuroimaging) and for screening compounds to prevent or modify disease progression in humans. A variety of ADRD mouse models have been developed to advance research into the underlying molecular and cellular mechanisms, to identify therapeutic targets, and to test therapeutic candidates. While existing ADRD mouse models have enabled progress toward each of these objectives, those available to date do not recapitulate the full spectrum and complexity of the molecular, cellular, behavioral and cognitive pathology observed in typical dementias. Several lines of evidence suggest that marmosets have emerged as a non-human primate model for both basic and translational neuroscience to bridge the gap between mice and humans. First, marmosets and humans have very similar complexity in brain structures, cognitive/social behavioral repertoires, metabolisms and immune functions. Second, as compared to other primates, it is highly economical and scalable for understanding brain functions and preclinical tests because they have a short lifespan, small body size, and high reproductive power. Finally, a set of gene editing tools is available to generate various types of genetically modified marmosets. Several lines of evidence led us to elucidate the role of the triggering receptor expressed on myeloid cells 2 (TREM2) pathways in ADRD. First, homozygous TREM2 null mutations have been linked to a recessive early-onset dementia syndrome called Nasu–Hakola disease. Several TREM2 variants are pathologic to FTD and a major risk factor/modifier for AD, Parkinson's disease, and amyotrophic lateral sclerosis (see https://www.alzforum.org/mutations/trem2). TREM2 mutation precipitates changes in vascular changes and blood brain barrier damages and may contribute to VCID. Second, microglia have emerged as a key cell type in the maintenance of central nervous system homeostasis, for which TREM2 mediates multiple critical signaling pathways. Third, aging is a major risk factor for ADRD. Decreased TREM2 expression during aging may accelerate ADRD development. Taken together , TREM2 is poised to influence neuronal and vascular systems associated with the development of multiple forms of ADRD. To elucidate the role of TREM2 in ADRD, different genetically modified marmosets will be generated and characterized.

摘要 该项目的长期目标是在更长的寿命中模拟阿尔茨海默病相关痴呆（ADRD）。 哺乳动物这些多维哺乳动物ADRD模型，包括额颞叶变性（FTD）， 路易体痴呆（LBD），血管对认知障碍和痴呆的贡献（VCID），以及混合 病因性痴呆，旨在告知人类ADRD跨越疾病相关阶段，并作为 研究疾病机制和确定治疗靶点的工具。ADRD的发展是由于 前驱期是大脑中长时间发生的一系列复杂事件， 在临床诊断痴呆症之前，人类需要10-20年。了解这个早期阶段将是 对于开发诊断工具至关重要（例如，神经成像）和用于筛选化合物， 预防或改变人类疾病的进展。已经开发了多种ADRD小鼠模型， 推进对潜在分子和细胞机制的研究，以确定治疗靶点，并 测试治疗候选人。虽然现有的ADRD小鼠模型已经实现了对每一个的进展， 目标，迄今为止可用的那些并不能概括分子的全部谱和复杂性， 在典型痴呆中观察到的细胞、行为和认知病理学。一些证据表明 绒猴已经成为基础和转化神经科学的非人类灵长类动物模型 来弥合小鼠和人类之间的差距。首先，绒猴和人类有非常相似的复杂性， 大脑结构、认知/社会行为库、代谢和免疫功能。二是作为 与其他灵长类动物相比，它是非常经济和可扩展的了解大脑功能， 临床前试验，因为它们寿命短，体型小，繁殖能力高。最后 一套基因编辑工具可用于生成各种类型的转基因绒猴。几行 的证据使我们阐明了触发受体表达的髓样细胞2（TREM 2）的作用， ADRD中的路径。首先，纯合子TREM 2无效突变与隐性早发性 痴呆综合症称为纳苏-哈科拉病。几种TREM 2变体是FTD的病理性变体， AD、帕金森病和肌萎缩侧索硬化症的危险因素/修饰因子（见 https://www.alzforum.org/mutations/trem2). TREM 2突变可促进血管变化， 血脑屏障损伤，可能导致VCID。其次，小胶质细胞已经成为一种关键的细胞类型， 在维持中枢神经系统稳态中，TREM 2介导多种关键的 信号通路第三，衰老是ADRD的主要危险因素。衰老过程中TREM 2表达减少 可能加速ADRD的发展。两者合计 TREM 2有望影响神经元和血管 与多种形式ADRD发展相关的系统。为了阐明TREM 2在ADRD中的作用， 将产生不同的转基因狨猴并进行表征。